Novartis Drops Presbyopia Drug Acquired With Encore Vision
Leisinger and Schmitt did not think that “throwing money” at complications resulted in options rather, they looked for innovative methods to address challenges and crises. But offered the unusual nature of the request, Leisinger and Schmitt had to make a decision whether the foundation should really help launch this plan. The Novartis Foundation’s initiatives aim to boost the health of low-income populations. In that capacity he discovered about the pharmaceutical sector and decided he wanted to be portion of it. But in 2018, soon following turning 41, he became chief executive of the drugs giant, which had annual revenues of...